Quantitative nuclear histomorphometry predicts oncotype DX risk categories for early stage ER+ breast cancer

BACKGROUND: Gene-expression companion diagnostic tests, such as the Oncotype DX test, assess the risk of early stage Estrogen receptor (ER) positive (+) breast cancers, and guide clinicians in the decision of whether or not to use chemotherapy. However, these tests are typically expensive, time cons...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Whitney, Jon, Corredor, German, Janowczyk, Andrew, Ganesan, Shridar, Doyle, Scott, Tomaszewski, John, Feldman, Michael, Gilmore, Hannah, Madabhushi, Anant
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5977541/
https://ncbi.nlm.nih.gov/pubmed/29848291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4448-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados